U.S. Complex and Chronic Condition Management Market Revenue to Attain USD 15.93 Bn by 2033

06 Dec 2024

Share :

Table of Content

1. U.S. Complex and Chronic Condition Management Market Revenue and Trends 2023 to 2033 2. Market Overview  3. Report Highlights of the U.S. Complex and Chronic Condition Management Market  4. U.S. Complex and Chronic Condition Management Market Trends 5. U.S. Complex and Chronic Condition Management Market Coverage 6. Market News

U.S. Complex and Chronic Condition Management Market Revenue and Trends 2023 to 2033

The U.S. complex and chronic condition management market revenue is predicted to attain around USD 15.93 billion by 2033 from USD 5.39 billion in 2024, at a CAGR of 13.32% during the forecast period. The rising instances of complex conditions are a major factor boosting the growth of the market.

Market Overview 

Complex conditions refer to patients living with complicated health issues, such as diabetes, mental health disorders, chronic respiratory disorders, and cardiovascular diseases (CVDs), for a longer period and progressing over time. Complex and chronic condition management involves the use of various technologies and services, which provide better treatment and help patients improve their quality of life. The market is experiencing significant growth due to the rise in the use of digital technologies in complex and chronic condition management.  

The rising prevalence of chronic diseases, such as cancer, diabetes, COPD, and cardiovascular and musculoskeletal disorders, is a major factor driving the growth of the market in the coming years. Chronic diseases are one of the major causes of death in the U.S. Moreover, the increasing geriatric population contributes to market expansion, as older people are more prone to chronic diseases. 

Complex and chronic condition management enhances individuals' quality of life by providing proper treatment, such as medication management, counseling, lifestyle modifications and therapy, and monitoring and managing symptoms. It also supports daily living activities like coordinating medical appointments, managing medications, and accessing resources. Rising healthcare expenditures further propel the market.

Report Highlights of the U.S. Complex and Chronic Condition Management Market 

• By disease type, the cardiovascular diseases segment dominated the market with the largest share in 2023. This is mainly due to the increase in cases of cardiovascular disease. According to the CDC, heart disease is the key cause of death in the U.S. One person dies every 33 seconds from CVDs. In 2022, about 702,880 people died from CVDs, which is equivalent to one in every five deaths. 
• By service, the implementation services segment led the market in 2023, as effective implementation of management programs is crucial in delivering comprehensive care to patients. The increasing prevalence of chronic conditions such as cancers, reproductive disorders, and musculoskeletal disorders, which require proper therapy and tests, is driving the segmental growth. 

U.S. Complex and Chronic Condition Management Market Trends

Rising Elderly Population

The increasing geriatric population is boosting the market's growth. Older people are more susceptible to chronic diseases, such as diabetes, heart disease, cancer, arthritis, and Alzheimer's disease, which require proper treatment and regular monitoring to manage conditions. The elderly population demands effective management strategies to improve the quality of care and reduce hospitalization and costs.

Advancements in Technologies

Many biopharmaceutical companies are investing heavily in research and development to develop new treatment options for complex chronic diseases. New drug classes, digital health tools, and innovative devices improve patient outcomes and condition management. Advanced therapeutic methods are now available to reduce symptoms of conditions like heart disease, cancer, or diabetes.

The implementation of digital technologies with advanced software systems helps patients identify any other complications and provides better treatment. It connects the patient's devices, such as smartphones and tablets, with electronic health records that analyze the patient's health, process the data, and provide notifications about diagnosis and treatment.

• For instance, in January 2024, Eli Lilly introduced the LillyDirect digital platform in the U.S. for patients with obesity, migraine, and diabetes. The platform offers disease management resources, including access to independent healthcare providers, tailored support, and direct home delivery of medicines through third-party pharmacy dispensing services. It also provides a digital pharmacy for selecting medicines by giving patients a simple option for the prescribed medicines, along with educational information to help empower and support patients on their care journeys.

Rising Adoption of Telehealth and mHealth Solutions

The increasing demand for telehealth and mHealth solutions is fueling the growth of the U.S. complex and chronic condition management market. Digital technologies, like smartphones and wearable devices, are helping individuals monitor their health by offering comfort and better management. Complex and chronic diseases such as heart disease, diabetes, and respiratory conditions require long-term treatment and regular monitoring. However, patients can monitor their condition through mobile apps by tracking vital signs, dietary habits, medication intake, and patterns that trigger the disease. The data collected through the Bluetooth-enabled devices are further forwarded to healthcare professionals so that they can create tailored treatment plans and improve patient outcomes.

U.S. Complex and Chronic Condition Management Market Coverage

Market News

• In August 2024, Amneal Pharmaceuticals, Inc. announced that the U.S. FDA has approved CREXONT extended-release capsules for the treatment of Parkinson’s disease (PD).
• In March 2024, UTMHealthcare in partnership with Somml Health launched NuLink Health, a virtual care platform to provide optimal care for patients with complex chronic conditions with the goal of minimizing hospital readmissions of the patients.

Market Segmentation

By Disease Type

• Cardiovascular Diseases
• Oncology
• Musculoskeletal
• Women’s Health/Fertility/Maternity
• Chronic Obstructive Pulmonary Disease
• Others

By Service

• Consulting Service
• Implementation Service
• Education Service
• Others

Get this report to explore global market size, share, CAGR and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/checkout/1455

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344